Letter from the President
In this first issue of The Visionary in 2019, I’d like to propose a toast to all the ROI’s supporters. You make the work of the Institute possible and are critical to its success. I’m pleased to share that you helped the ROI have one of its best years yet both in terms of the research that is demonstrating the life-saving and quality-of-life benefits of radiation therapy for cancer patients and the contributions that are necessary to sustain it.
Over the past year, the ROI awarded more than $200,000 in grants to researchers who are investigating issues important to practitioners and patients alike, including financial toxicity, access to care, awareness and telehealth. Results from ROI-funded research continued to grow as investigators published manuscripts in Advances in Radiation Oncology and JAMA Otolaryngology among other journals and presented at the Annual Meetings of ASTRO and AAPM. (Be sure to listen to the new podcast with ROI researcher Todd McNutt, PhD, discussing his results demonstrating how the spatial distribution of the radiation dose influences toxicities.) The 2018 ROI Publication Award winner was selected from many excellent manuscripts submitted for consideration, and this year’s nomination, which is now open, should once again offer an exciting competition. Finally, the ROI’s Personalized Radiation Therapy funding opportunity saw a record number of applications submitted, and we are looking forward to announcing these new research awards soon.
Your support is the foundation for these successes, and you gave generously last year, significantly outpacing prior years. Some of you donated for the first time, others have been with us since the very beginning. We are grateful to all of you and hope you will renew your commitment in 2019. We look forward to welcoming many new donors this year as well. Together, we can continue to support research to ensure that radiation oncology is a leader in cancer care.
So here’s my toast. May you continue to see the results of your investment in the ROI grow. May you and your patients benefit from the advances in radiation oncology made possible through ROI research. May you see a day when all patients who can benefit from radiation therapy actually receive it.
Cheers to you, our donors!
Deborah A. Kuban, MD, FASTRO